Background & objectives: The COVID-19 pandemic, caused with the infection of
SARS-CoV-2, is long lasting, and there is no specific treatment for the disease.
The current study authenticates, using bioinformatic approaches, the
inhibition of SARS-CoV-2 3CLpro with three bioactive phytochemicals
alkaloid L27, eupatorium and L-hyoscyamine from Lycopodium clavatum,
Eupatorium perfoliatum and Atropa belladonna, respectively. Methods: Molecular
docking, ADMET, drug‐likeness analysis, molecular dynamics (MD)
simulation, and free energy calculation were applied to 3CLpro interaction
with alkaloid L27, eupatorium and L-hyoscyamine, for the determination of
pharmacological efficacy, safety evaluation, to assess the dynamics and
energetics of these complexes. Results: Molecular docking demonstrated
binding energy ≤ -6.5 kcal/mol for the phytochemicals used as ligands. No
violation of Lipinski’s RO5, favourable ADMET properties and bioavailability
scores (0.55) signify the suitability of drug-likeness for the selected ligands.
Molecular dynamic simulation revealed the root mean square (RMS) deviation
of ~ 0.12 nm about the protein backbone, and RMS fluctuations < 0.2 nm about
the ligand-heavy atoms, indicating the stability of protein-ligand complex
structures throughout the simulation course. Interpretation & conclusions: The
key amino acid players in protein-ligand interactions were Lys5, Met6, Ala7
and Val125 through H-bond and hydrophobic bond formation. Though net
binding free energy of 3CLPro with eupatorium (-121.36 kJ/mol) was more
favorable than lycopodium (-114.17 kJ/mol) and L-hyoscyamine (-78.96
kJ/mol), all the ligands were found effective to inhibit the 3CLpro of SARSCoV-2. Thus, the compounds alkaloid L27 from Lycopodium, eupatorium,
and L-hyoscyamine might be useful in the management of COVID-19
associated symptoms
Keywords: Atropa belladonna, Eupatorium perfoliatum, Lycopodium
clavatum, molecular docking, molecular dynamics simulation, SARS-CoV-2
3CLpro